164 related articles for article (PubMed ID: 32435191)
1. Inhibition of K
Citerni C; Kirchhoff J; Olsen LH; Sattler SM; Grunnet M; Edvardsson N; Bentzen BH; Diness JG
Front Pharmacol; 2020; 11():556. PubMed ID: 32435191
[TBL] [Abstract][Full Text] [Related]
2. The K
Kirchhoff JE; Skarsfeldt MA; Muthukumarasamy KM; Simó-Vicens R; Bomholtz SH; Abildgaard L; Jespersen T; Sørensen US; Grunnet M; Bentzen BH; Diness JG
Front Pharmacol; 2019; 10():668. PubMed ID: 31275147
[No Abstract] [Full Text] [Related]
3. Inhibition of K
Diness JG; Abildgaard L; Bomholtz SH; Skarsfeldt MA; Edvardsson N; Sørensen US; Grunnet M; Bentzen BH
Front Pharmacol; 2020; 11():749. PubMed ID: 32508659
[TBL] [Abstract][Full Text] [Related]
4. Termination of Vernakalant-Resistant Atrial Fibrillation by Inhibition of Small-Conductance Ca
Diness JG; Skibsbye L; Simó-Vicens R; Santos JL; Lundegaard P; Citerni C; Sauter DRP; Bomholtz SH; Svendsen JH; Olesen SP; Sørensen US; Jespersen T; Grunnet M; Bentzen BH
Circ Arrhythm Electrophysiol; 2017 Oct; 10(10):e005125. PubMed ID: 29018164
[TBL] [Abstract][Full Text] [Related]
5. The K
Diness JG; Kirchhoff JE; Speerschneider T; Abildgaard L; Edvardsson N; Sørensen US; Grunnet M; Bentzen BH
Front Pharmacol; 2020; 11():159. PubMed ID: 32180722
[TBL] [Abstract][Full Text] [Related]
6. Effective termination of atrial fibrillation by SK channel inhibition is associated with a sudden organization of fibrillatory conduction.
Gatta G; Sobota V; Citerni C; Diness JG; Sørensen US; Jespersen T; Bentzen BH; Zeemering S; Kuiper M; Verheule S; Schotten U; van Hunnik A
Europace; 2021 Nov; 23(11):1847-1859. PubMed ID: 34080619
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of SK-channels with AP14145 prevents atrial arrhythmogenic changes in a porcine model for obstructive respiratory events.
Linz B; Hesselkilde EM; Skarsfeldt MA; Hertel JN; Sattler SM; Yan Y; Tfelt-Hansen J; Diness JG; Bentzen BH; Linz D; Jespersen T
J Cardiovasc Electrophysiol; 2023 Jan; 34(1):126-134. PubMed ID: 36482155
[TBL] [Abstract][Full Text] [Related]
8. Arrhythmia development during inhibition of small-conductance calcium-activated potassium channels in acute myocardial infarction in a porcine model.
Lubberding AF; Sattler SM; Grunnet M; Sørensen US; Tfelt-Hansen J; Jespersen T
Europace; 2019 Oct; 21(10):1584-1593. PubMed ID: 31408093
[TBL] [Abstract][Full Text] [Related]
9. Effect of antiarrhythmic drugs on small conductance calcium - activated potassium channels.
Simó-Vicens R; Sauter DRP; Grunnet M; Diness JG; Bentzen BH
Eur J Pharmacol; 2017 May; 803():118-123. PubMed ID: 28322838
[TBL] [Abstract][Full Text] [Related]
10. Trigger-Specific Remodeling of K
Rahm AK; Gramlich D; Wieder T; Müller ME; Schoeffel A; El Tahry FA; Most P; Heimberger T; Sandke S; Weis T; Ullrich ND; Korff T; Lugenbiel P; Katus HA; Thomas D
Pharmgenomics Pers Med; 2021; 14():579-590. PubMed ID: 34045886
[TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmic effect of the Ca
Kirchhoff JE; Diness JG; Abildgaard L; Sheykhzade M; Grunnet M; Jespersen T
Pflugers Arch; 2016 Nov; 468(11-12):1853-1863. PubMed ID: 27722784
[TBL] [Abstract][Full Text] [Related]
12. Characterization of in vivo and in vitro electrophysiological and antiarrhythmic effects of a novel IKACh blocker, NIP-151: a comparison with an IKr-blocker dofetilide.
Hashimoto N; Yamashita T; Tsuruzoe N
J Cardiovasc Pharmacol; 2008 Feb; 51(2):162-9. PubMed ID: 18287884
[TBL] [Abstract][Full Text] [Related]
13. Reduced ventricular proarrhythmic potential of the novel combined ion-channel blocker AZD1305 versus dofetilide in dogs with remodeled hearts.
Johnson DM; de Jong MM; Crijns HJ; Carlsson LG; Volders PG
Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):201-9. PubMed ID: 22080293
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Atrial and Ventricular Structural Remodeling in a Porcine Model of Atrial Fibrillation Induced by Atrial Tachypacing.
Citerni C; Kirchhoff J; Olsen LH; Sattler SM; Gentilini F; Forni M; Zannoni A; Grunnet M; Edvardsson N; Bentzen BH; Diness JG
Front Vet Sci; 2020; 7():179. PubMed ID: 32328502
[No Abstract] [Full Text] [Related]
15. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
[TBL] [Abstract][Full Text] [Related]
16. Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs.
Wirth KJ; Paehler T; Rosenstein B; Knobloch K; Maier T; Frenzel J; Brendel J; Busch AE; Bleich M
Cardiovasc Res; 2003 Nov; 60(2):298-306. PubMed ID: 14613859
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of I
Juhász V; Hornyik T; Benák A; Nagy N; Husti Z; Pap R; Sághy L; Virág L; Varró A; Baczkó I
Can J Physiol Pharmacol; 2018 Jan; 96(1):18-25. PubMed ID: 28892643
[TBL] [Abstract][Full Text] [Related]
18. Dofetilide reduces the incidence of ventricular fibrillation during acute myocardial ischaemia. A randomised study in pigs.
Andersen HR; Wiggers H; Knudsen LL; Simonsen I; Thomsen PE; Christiansen N
Cardiovasc Res; 1994 Nov; 28(11):1635-40. PubMed ID: 7842456
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
Valembois L; Audureau E; Takeda A; Jarzebowski W; Belmin J; Lafuente-Lafuente C
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005049. PubMed ID: 31483500
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.
Liu G; Xue X; Gao C; Huang J; Qi D; Zhang Y; Dong JZ; Ma CS; Yan GX
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28522677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
